NDC 13985-566 - GenOne
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-566
- Package NDCs from labels
- 13985-566-60, 13985-566-12, 13985-566-24
- Manufacturer
- MWI | FIRST PRIORITY INCORPORATED
- Effective date
- 2023-09-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GenOne - MWI | FIRST PRIORITY INCORPORATED | MWI | FIRST PRIORITY INCORPORATED | 2023-09-26 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-566-12 | GenOne | 120 mL in 1 BOTTLE, SPRAY | SPRAY | 120 | 7 | |
| 13985-566-12 | GenOne | 12 in 1 CASE | SPRAY | 12 | 7 | |
| 13985-566-24 | GenOne | 240 mL in 1 BOTTLE, SPRAY | SPRAY | 240 | 7 | |
| 13985-566-24 | GenOne | 12 in 1 CASE | SPRAY | 12 | 7 | |
| 13985-566-60 | GenOne | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | 7 | |
| 13985-566-60 | GenOne | 12 in 1 CASE | SPRAY | 12 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BETAMETHASONE VALERATE | ACTIVE INGREDIENT | 9IFA5XM7R2 | GENONE (GENTAMICIN SULFATE) SPRAY [MWI] | 5 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENONE (GENTAMICIN SULFATE) SPRAY [MWI] | 5 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | GENONE (GENTAMICIN SULFATE) SPRAY [MWI] | 5 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENONE (GENTAMICIN SULFATE) SPRAY [MWI] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN | Hikma Pharmaceuticals USA Inc. | 51fffac8-fb6e-4f7f-b2de-440252781a42 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE FOAM | Xiromed, LLC. | dee8f6d1-b0ba-3c56-f08d-eb6283b0b250 | 2023-05-08 | Warnings, Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | A-S Medication Solutions | 76fabcd6-4da3-49e3-85a1-ca4fac55a207 | 2023-05-08 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | a8b15217-cccb-2260-e053-2995a90a709d | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | 4cfbe37e-11d6-46fc-b287-0561387b17b7 | 2023-01-31 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | b59e49e0-640b-43c3-ad07-711d1bb154e9 | 2022-07-19 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 3a6677a6-def5-443e-82bc-c185d41f03b7 | 2022-06-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 036706f1-0a24-4765-9a62-820ad64934be | 2022-06-01 | Adverse reactions | 9IFA5XM7R2 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Cosette Pharmaceuticals, Inc. | 784476d2-5e5c-fdba-a677-8973a777b5ef | 2022-05-05 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | a54e5c95-609d-4d66-9573-5d1ac78fa58f | 2022-03-04 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | cf4386ba-c62a-4ee8-ab59-1bb2e737a5da | 2021-05-01 | Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 2a64b65b-8a49-45ea-9464-2269751c075c | 2021-04-01 | Adverse reactions | 9IFA5XM7R2 |
| Gentak | GENTAMICIN SULFATE | Proficient Rx LP | aebfe247-cdf7-4acb-97b3-6d4341d7c815 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 2098faaa-7f60-4640-8c37-19456ebba653 | 2019-11-01 | Warnings, Adverse reactions | 8X7386QRLV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.